Subscribe | Blood Cancers Today
Sign up for Blood Cancers Today eNewsletters to join an extensive community of hematologic oncology professionals and get the latest news and insights from the field.
Sign up for Blood Cancers Today eNewsletters to join an extensive community of hematologic oncology professionals and get the latest news and insights from the field.
Theme Time Radio Hour, with your host Bob DylanEpisode 80, Blood First aired, 12th November 2008Converted from lossless flac audio files__I uploaded this one…
At a median follow-up of 18.1 months, the ORR and CR rates were both 95.7% following liso-cel treatment.
Hormonal Therapy, Venous thromboembolic disease, Anticoagulation, and Abnormal Uterine Bleeding with Dr. Bethany Samuelson Bannow Explore the intersection of hematology and women’s health as we…
D-KRd induction and consolidation with double transplant is feasible in HR TE-NDMM.D-KRd with double transplant result in high rates of MRD negativity, PFS
Increased global temperature is associated with a wide range of health risks, which are disproportionately high for certain populations. Individual- and population-level measures can reduce…
Dr. Hilal covers the debates surrounding MRD, whether he uses MRD to make treatment decisions, and more.
Monotherapy with tagraxofusp induced complete remissions in patients with blastic plasmacytoid dendritic cell neoplasm.
Research To Practice requires users to log in to view educational content. All content is available without
Dr. Hilal covers the debates surrounding MRD, whether he uses MRD to make treatment decisions, and more.
EHA Library; Eyre T. Jun 13 2024; 420720;